Publications

Is Nuchal Translucency of 3.0-3.4 Mm an Indication for Cfdna Testing or Microarray? - A Multicenter Retrospective Clinical Cohort Study

AuthID
P-017-4PF

Author(s)

Rybak-Krzyszkowska, M

Madetko-Talowska, A

Szewczyk, K

Bik-Multanowski, M

Sakowicz, A

Stejskal, D

Trková, M

Smetanová, D

Serafim, S

Correia, H

Nevado, J

Mori, MA

Mansilla, E

Rutkowska, L

Kucinska, A

Gach, A

Huras, H

Kolak, M

Srebniak, MI

Document Type

Article

Year published

2024

Published

in FETAL DIAGNOSIS AND THERAPY, ISSN: 1015-3837

Volume: 51, Issue: 5, Pages: 453-462 (10)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1159/000539463

Pubmed: 38815555

Scopus: 2-s2.0-85205604529

Wos: WOS:001328781600008

Source Identifiers

ISSN: 1015-3837

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Is Nuchal Translucency of 3.0-3.4 Mm an Indication for Cfdna Testing or Microarray? - A Multicenter Retrospective Clinical Cohort Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Is Nuchal Translucency of 3.0-3.4 Mm an Indication for Cfdna Testing or Microarray? - A Multicenter Retrospective Clinical Cohort Study

Useful Links

Get Help